The EpiOncology online data platform provides you with unparalleled cancer epidemiology data sets. Using EpiOncology, you can examine cancer data from 42 countries. Leverage Epiphany’s patient flow models. Forecast trends. Incorporate global data in your own projects. Model the impact of completely new cancer treatments.

EpiOncology gives you unmatched cancer coverage. More than 55 cancer sites with 110+ subtypes/biomarkers…over 95% of the cancer incidence worldwide.

All within an easy-to-use interface that gives you full transparency, Save and Download data options, and a collaboration feature to communicate directly with your EpiOncology team. It’s our core product…and your way to see the future of cancer.

Not only does EpiOncology include over 55 cancer sites with 110+ subtypes/biomarkers…you can confirm all of the data yourself. Our data set is fully transparent. We include sources and use an open model. You won’t find data coverage this broad or deep anywhere else.

All EpiOncology subscriptions come with support from our team’s epidemiology experts. We answer most inquiries within 24 hours.

What kind of support should you expect? EpiOncology customers can take advantage of monthly Web conferences with the Epiphany Partners team, help with data analysis and implementation, help with benchmarking, on-site training for the EpiOncology platform, and more.

EpiOncology’s data availability is consistent across all of Epiphany’s study countries.

Here’s an example. These screenshots from the EpiOncology platform illustrate radiochemotherapy for Stage IV gastric cancer in the U.S., France, and Japan. Three different countries, with the same treatment data for the same measurement period (2010 to 2040 projected). Globally consistent cancer data.